DRExplainer: Quantifiable Interpretability in Drug Response Prediction with Directed Graph Convolutional Network
Haoyuan Shi, Tao Xu, Xiaodi Li, Qian Gao, Zhiwei Xiong, Junfeng Xia,, Zhenyu Yue

TL;DR
DRExplainer is a novel directed graph convolutional network model that predicts drug responses in cancer cell lines and provides quantifiable interpretability by identifying relevant biological subgraphs, outperforming existing methods.
Contribution
It introduces a directed bipartite network framework with a mask learning approach for interpretability and quantifiable explanations in drug response prediction.
Findings
Outperforms state-of-the-art predictive methods.
Provides quantifiable interpretability with biological validation.
Effective in case studies for novel drug response prediction.
Abstract
Predicting the response of a cancer cell line to a therapeutic drug is pivotal for personalized medicine. Despite numerous deep learning methods that have been developed for drug response prediction, integrating diverse information about biological entities and predicting the directional response remain major challenges. Here, we propose a novel interpretable predictive model, DRExplainer, which leverages a directed graph convolutional network to enhance the prediction in a directed bipartite network framework. DRExplainer constructs a directed bipartite network integrating multi-omics profiles of cell lines, the chemical structure of drugs and known drug response to achieve directed prediction. Then, DRExplainer identifies the most relevant subgraph to each prediction in this directed bipartite network by learning a mask, facilitating critical medical decision-making. Additionally, we…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsComputational Drug Discovery Methods · Metabolomics and Mass Spectrometry Studies · Machine Learning in Materials Science
